Results 81 to 90 of about 4,291 (203)

Herpetiform pemphigus with anti-Dsg 1 and full-length BP180 autoantibodies

open access: yesEuropean Journal of Dermatology, 2012
ejd.2012.1643 Auteur(s) : Yuta Kurashige1 kurasige@tokyo-med.ac.jp, Yoshihiko Mitsuhashi1, Masuyoshi Saito1, Shunpei Fukuda2, Takashi Hashimoto2, Ryoji Tsuboi1 1 Department of Dermatology, Tokyo Medical University, 6-7-1 Nishishinjuku Shinjuku-ku, Tokyo 160-0023, Japan 2 Department of Dermatology, Kurume University, Kurume, Japan Herpetiform pemphigus (
Yuta, Kurashige   +5 more
openaire   +3 more sources

Ectoplasmic specialization: A friend or a foe of spermatogenesis? [PDF]

open access: yes, 2006
The ectoplasmic specialization (ES) is a testis-specific, actin-based hybrid anchoring and tight junction. It is confined to the interface between Sertoli cells at the blood-testis barrier, known as the basal ES, as well as between Sertoli cells and ...
Mruk, DD, Lee, WM, Cheng, CY, Yan, HHN
core   +5 more sources

A comparative study of expression of Fc receptors in relation to the autoantibody-mediated immune response and neutrophil elastase expression in autoimmune blistering dermatoses

open access: yesPolish Journal of Pathology, 2017
Here we investigated the cutaneous CD32A and CD89 expression in relation to the neutrophil elastase (NE) expression and serum level of anti-desmoglein 1 and 3 (DSG1/DSG3) IgG in pemphigus, anti-BP180/BP230 IgG in bullous pemphigoid (BP), anti-gliadin ...
Justyna Gornowicz-Porowska   +6 more
doaj   +1 more source

Massachusetts Health Reform: Solving the Long-Run Cost Problem [PDF]

open access: yes, 2009
Outlines options for controlling the long-term costs of the state's universal health insurance, including managed competition, a new public insurance option, a semi-public agency to coordinate programs negotiating rates, and all-payer rate ...
John Holahan, Linda J. Blumberg
core  

Complement activation in inflammatory skin diseases [PDF]

open access: yes, 2018
The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria, viruses, and fungi. Activation of complement results in production of several molecules mediating
Damman, J. (Jeffrey)   +5 more
core   +7 more sources

Type XVII Collagen (BP180) and LAD-1 are Present as Separate Trimeric Complexes [PDF]

open access: yesJournal of Investigative Dermatology, 1999
This study characterized the high molecular mass BP180 complex that is observed when unheated sodium dodecyl sulfate extracts of human skin or keratinocytes are subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting.
Pas, HH   +5 more
openaire   +3 more sources

Bullous Wells’ syndrome successfully treated with omalizumab

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Giulia Ciccarese   +7 more
wiley   +1 more source

Hemidesmosome Mutations Contribute to the Onset and Severity of Acquired Autoimmune Bullous Diseases

open access: yesMedComm, Volume 7, Issue 3, March 2026.
This study examined hemidesmosome assembly‐related genes in pemphigoid diseases, revealing variants linked to disease onset and severity. Functional analyses, including Caenorhabditis elegans models, Ker‐CT transcriptomics, human proteomics, etc., demonstrated that ITGA6 mutations destabilize hemidesmosomes, disrupt dermal–epidermal adhesion, and ...
Shan Cao   +19 more
wiley   +1 more source

Relation between antibodies to BP180 and gender in bullous pemphigoid

open access: yesJournal of the American Academy of Dermatology, 1999
Bullous pemphigoid is associated with antibodies to 2 basement membrane zone antigens (BP230 and BP180). In some patients antibodies develop to one of these antigens, whereas in others antibodies develop to both. Although the factors behind this are unknown, our study indicates that male gender is one factor.
D, Jiao, J C, Bystryn
openaire   +2 more sources

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

open access: yesThe Journal of Dermatology, Volume 53, Issue 3, Page 399-409, March 2026.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy